R333 (Pantoprazole Sodium Delayed Release 40 mg)
Pill with imprint R333 is Yellow, Round and has been identified as Pantoprazole Sodium Delayed Release 40 mg. It is supplied by Dr. Reddy’s Laboratories Inc.
Pantoprazole is used in the treatment of barrett's esophagus; erosive esophagitis; duodenal ulcer; gerd; gastritis/duodenitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 40 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for R333
- 40 mg
- 8.00 mm
- Prescription only
- Drug Class
- Proton pump inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Dr. Reddy’s Laboratories Inc.
- Inactive Ingredients
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
polyethylene glycol 400,
ferric oxide yellow,
Note: Inactive ingredients may vary.
Labelers / Repackagers
|NDC Code||Labeler / Repackager|
|55111-0333||Dr. Reddy's Laboratories, Inc.|
|00904-6235 (Discontinued)||Major Pharmaceuticals|
Related images for "R333"
More about pantoprazole
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (383)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: proton pump inhibitors
- Drug Information
- Pantoprazole (Advanced Reading)
- Pantoprazole Intravenous (Advanced Reading)
- Pantoprazole Delayed-Release Granules
- Pantoprazole Delayed-Release Tablets
- Pantoprazole Injection
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.